Covaxin rolled out in Bengal, 60 beneficiaries to be inoculated on Day 1

The West Bengal health department on Wednesday rolled out Covaxin, developed by Bharat Biotech, at three vaccination centres in the city

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Press Trust of India Kolkata
1 min read Last Updated : Feb 03 2021 | 2:15 PM IST

The West Bengal health

department on Wednesday rolled out Covaxin, developed by Bharat Biotech, at three vaccination centres in the city -- each set to inoculate 20 frontline COVID-19 warriors during the day -- an official said.

The three centres -- state-run SSKM hospital, RG Kar Medical College and Hospital and Kolkata Medical College and Hospital - would be administering the vaccines to health and civic workers, after they sign a consent form.

"Everyone receiving Covaxin doses are required to sign an informed consent form. Today, a total of 60 beneficiaries at the three sites will be administered this vaccine. We do not want to take any chance. Slowly and slowly, we will speed up the process," the official told.

So far, Covishield, manufactured by Pune-based Serum Institute of India, has been administered to nearly three lakh people in Bengal.

Among those who received Covaxin on the first day are National Health Mission managing director Saumitra Mohan, its programme officer Smita Sanyal Sukla and Directorate of Medical Education head Dr Debasish Bhattacharya.

A second consignment of Covaxin vaccines reached the city from Hyderabad earlier in the day, the official added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Feb 03 2021 | 2:12 PM IST

Next Story